Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Prostate cancer
Trial Type:  Treatment
Trial Status:  Active
Results 1-25 of 520 for your search:
Start Over
Stereotactic Body Radiotherapy for Prostate Cancer
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-022, NCT01352598
Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy
Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: Thin-1, NCT01379742
Firmagon (Degarelix) Intermittent Therapy
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: CURC - FIT-0002, NCT01512472
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: R12-3104L, NCT01581749
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A-38-52014-194, NCT01753297
Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KEK-ZH-NR:2010-0004/0, NCT01770340
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2412, NCT01794793
Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: EC/2013/472, 2013-000782-36, NCT02001857
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: kk2013 MRI, NCT02102646
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9785-CL-0410, 2013-002271-17, NCT02116582
A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR106841, ABI-C-14-JP-001-V03, NCT02405858
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel Treatment in Patients Who Have Previously Received Enzalutamide
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9785-MA-1008, NCT02441517
Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CABAZL07239, U1111-1155-8055, NCT02441894
STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000455008, MRC-STAMPEDE, EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RRK4368, 2012-002552-16, NCT01668459
A PHASEII STUDY EVALUATING INTRAVENOUS MELPHALAN WITH AUTOLOGOUS WHOLE BLOOD STEM CELL TRANSPLANTATION (PBSCT)OVER THREE CYCLES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (MEL-CAP).
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MEL-CAP, NCT01907009
HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 40 to 75
Sponsor: Other
Protocol IDs: PROMOBRA-2013, NCT02258087
Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: KEK-ZH-Nr. 2013-0415, NCT02265159
Randomized, Multi-center Clinical Trial Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated Combined With Androgen Deprivation Therapy in a High Risk Group of Prostate Cancer Patients
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: Other
Protocol IDs: HYPOPROST, NCT02300389
Discovery Stage Clinical Study About Oncology Drugs and Single Nucleotide Polymorphisms
Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 22 and over
Sponsor: Other
Protocol IDs: ANDA208414, FWA00015357, IORG0007849, IRB00009424, IND78420, NPI1831468511, NPI1023387701, NCT02403505
Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000064184, SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, PR8, NCT00002651
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 75
Sponsor: Other
Protocol IDs: CDR0000416088, FRE-FNCLCC-GETUG-14/0207, EU-20503, NCT00104741
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 05-043, NCT00116142
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 79
Sponsor: Other
Protocol IDs: JCOG0401, C000000026, NCT00138008
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: R03-1213, NCT00175383
Start Over